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Background: The controversy between breast conserving surgery and simple mastectomy for phyllodes tumours of
the breast remains because of the unpredictable nature of the disease. Although some benign tumours may show
an unusually aggressive behaviour, modified radical surgery for phyllodes tumours offers no survival advantage, and
recently more conservative surgical approaches have been deployed.
Case presentation: A 30-year-old woman with a giant multifocal tumour of the breast underwent breast-conserving
surgery that made use of the well- circumscribed feature of the tumour. The case demonstrates the safety, and cosmetic
benefit of the breast-conserving approach for multifocal phyllodes tumours except for the high recurrence rate.
Conclusions: Large size, multifocality, and borderline or malignant histology are contraindications for breast-conserving
surgery.
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Phyllodes tumours of the breast are rare and account
for less than 1% of breast tumours [1]. Malignant trans-
formation of a phyllodes tumour is a rare form of breast
cancer accounting for just 0.5% of all breast cancers
[1,2]. Phyllodes tumours are fibroepithelial tumours
composed of a benign epithelial component and a more
numerous cellular spindle cell stroma forming charac-
teristic broad -“leaf-like”- (phullon) papillae inserted into
cleft-like epithelial spaces. The hypercellular stroma is the
neoplastic component [3]. The median size of phyllodes
tumour is around 4 cm. Twenty percent of tumours
grow larger than 10 cm- the arbitrary cut-off point for
designation as a giant tumour [1-3]. Studies have shown
no difference between breast- conserving surgery versus
mastectomy in terms of metastases free-survival or overall
survival despite the higher incidence of local recurrence
that comes with breast-conserving surgery [4,5]. Argu-
ments for over- and under- treating these patients remain
due to the difficulty of forming a clear diagnostic and* Correspondence: elroypat@yahoo.co.uk
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unless otherwise stated.therapeutic pathway in this highly variable disease. Wide
excision with a clear surgical margin is the preferred
therapy for phyllodes tumour. Re-excision is recommended
in cases with a positive surgical margin and stromal over-
growth and malignancy [4]. The giant phyllodes presents
with several unique management problems. A simple mast-
ectomy is performed for giant phyllodes tumours (>10 cm),
those that are multifocal, in cases of recurrence or in phyl-
lodes of ‘borderline’ histology [5]. Breast-conserving surgery
is traditionally avoided in large multifocal phyllodes because
of the risk of inadequate local excision and associated
high local recurrence [5-8]. We report a case of a recurrent,
rapidly growing but clinically benign giant multifocal
phyllodes tumour of the breast that was treated by breast-
conserving surgery for better cosmesis.
Case presentation
A 30- year- old lactating mother was admitted electively
for investigation of a recurrent rapidly growing mass in
her right breast over a period of 11 months. The mass was
initially noticed as a small painless lump in the upper,
outer quadrant of her breast when she was five months
pregnant. Results of a fine needle aspiration cytology
suggested a fibroadenoma. An ultrasound examinationLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Breast-conserving surgery for phyllodes tumour of
right breast. (Note redundant skin).
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portions of 86 mm and 62 mm in diameter and two axil-
lary lymph nodes of 17 mm and 15 mm but a definitive
diagnosis could not be made. Her left breast was entirely
unaffected. She breast- fed her current four- month- old
baby from both breasts. Two years previously, she under-
went the excision of a heterogeneous right-breast mass
but no precise diagnosis was made as the operative speci-
men was not histologically examined.
On examination she appeared clinically well with no
pallor or weight loss. Both breasts were lactating. Her
left breast was normal on palpation. Her right breast
was extremely large and heavy with palpable large focal
lumps. The major lump was greater than 10 cm in total
diameter (Figure 1). They appeared encapsulated and firm
in consistency. The masses were attached to adjacent
breast tissue but not to underlying muscle nor to overlying
skin. There was no skin tethering or nipple retraction
but a transverse scar in the upper outer quadrant. The
whole breast mass moved freely over the pectoralis major
and there were no palpable axillary or supraclavicular
lymphadenopathy. Chest and abdominal examination
were unremarkable. Her haemoglobin level and a chest
X-ray were normal.
Our patient gave consent to a wide local excision of
the tumour mass and not to mastectomy, despite being
informed of the risk of local recurrence. An elliptical skin
incision was made at the upper part of her breast over
the biggest mass and included the previous scar. A sub-
cutaneous flap was developed superiorly and inferiorly.
A cleavage plane of the biggest tumour (>10 cm in
diameter) in the upper inner quadrant was identified and
the tumour excised. Using the same incision, multiple
wide tumourectomies (enucleations) were performed.
Two further tumours in the outer upper and lower
quadrants were excised measuring about 8 cm in diam-
eter. Six further smaller tumours within the breast tissue
were removed (Figure 2). The tumours were identified on
palpation by their firmer consistency and circumscribed
margins as compared to normal breast tissue or the
other breast. There was no infiltration to the underlyingFigure 1 Giant phyllodes tumour of breast.pectoralis major muscle. There were no palpable axillary
lymph nodes intraoperatively and axillary dissection was
not performed.
Meticulous haemostasis was done with electrocautery
and suture ligation. The estimated blood loss was about
300 ml. The normal breast tissue was approximated
and the wound closed in layers. The skin was closed
with interrupted sutures. No drain was inserted. The
residual right breast volume was almost the same as the
left (Figure 3). The total operation time was 2 hours
30 minutes. She received prophylactic antibiotics and
analgesia. Her post operative haemoglobin level was
8 g/dl for which she received iron supplements. She
also received prophylactic antibiotics and analgesia. She
was discharged on the fifth post operative day with a
three-monthly follow-up.
The histopathological diagnosis of the tumour returned
as a borderline phyllodes tumour with moderate pleo-
morphism and three to four mitoses per ten high powerFigure 3 Operative Specimens (Phyllodes tumours).
Figure 5 Benign Phyllodes tumour histology (haematoxylin and
eosin stained) showing benign epithelia and a spindle stoma.
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present without any lymphovascular invasion.
Four months later she returned with a rapidly progres-
sing local recurrence of phyllodes tumours in the same
quadrants of the breast for which she underwent a
simple mastectomy.
Discussion
Phyllodes tumours of breast are rare (2.1 per million)
and usually benign. They are more common in Latin
American (Hispanic) women [7]. On histology they are
fibro-epithelial tumours similar to fibroadenomas except
for the hypocellular stroma with few mitoses and a true
capsule present in fibroadenoma [3]. They occur over a
wide age range with a median age of 45 years, 20 years
later than fibroadenoma. It has been postulated that
stromal induction of phyllodes tumour can occur as a
result of growth factor produced by the breast epithelium
[9]. The presence of sex hormones in pregnancy may
stimulate the growth of these tumours. Triple assessment
by clinical, radiological and cytological or histopatho-
logical examination individually or in combination gives
poor diagnostic accuracy for phyllodes tumours [1,10].
Macroscopically, small tumours usually resemble fibro-
adenomas but tumours can grow rapidly to over 20 cm
in diameter [2]. Involvement of axillary nodes is rare in
phyllodes tumour and axillary dissection is not indicated.
However, axillary lymph node metastases occur in about
10% of patients with malignant phyllodes [2]. The two
small impalpable axillary lymph nodes identified by
ultrasound were probably reactive. Needle core biopsy
rarely produces a definite pre-operative diagnosis because
this tumour shares many cytological features with fibro-
adenoma. One series showed a pre-operative diagnosis of
phyllodes tumour in only 10% to 20% of cases [11]. Large
tumours often have a fleshy appearance with cystic
and necrotic areas (Figure 5) [2]. Microscopically,
epithelioid-lined cystic spaces with hypercellular stroma
confirms the diagnosis. An equivocal diagnosis ofFigure 4 Fleshy appearance with cystic and necrotic areas.phyllodes tumour should not prevent excision if clinical
suspicion remains [12].
Wide tumourectomy is the mainstay of treatment and the
high recurrence rate of 37% in one series justifies wide mar-
gin excision [13]. Local recurrence rates are correlated with
positive excision margins. [11] Although mastectomy has
invariably been performed for larger tumours, to date, there
is no correlation between tumour size and risk of local re-
currence. Other studies have shown a higher risk of local
recurrence in borderline and malignant tumours [1,5]. By
contrast patients treated with mastectomy (subcutaneous,
simple, modified-radical) showed no evidence of local
recurrence [14]. Local recurrence usually occurs within
the first few years of surgery and histologically resem-
bles the original tumour [12]. The recurrences in our
patient may have been due to incomplete excisions as
recurrence occurred in the same quadrants of the breast.
Thus intra-operative ultrasound may be more useful than
palpation in detecting the phyllodes tumours. Patients
with giant phyllodes may have clinically enlarged axillary
lymph nodes that may be suspicious for metastatic dis-
ease. The surgeon may be forced to proceed with axillary
lymph node dissection especially as sentinel lymph node
biopsy may not be accurate in these patients [5]. The con-
troversy between breast-conserving surgery and mastec-
tomy remains because of the unpredictable nature of the
disease. Contraindications for breast- conserving surgery
include large tumours, multifocality, borderline histology
and malignancy because of their greater risk of recurrence.
However, local recurrence can always be managed by fur-
ther wide excision if there is no evidence of borderline
pathology or malignancy [1,2,12]. Histological type is the
most important predictor for metastatic spread, although
it may not correlate with clinical behaviour because both
malignant and borderline tumours are capable of metasta-
sizing. The five year survival for benign, borderline or
malignant tumours is 96%, 74% and 66% respectively
[15]. Tumour size is an important factor in predicting
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elements in large tumours and the fact that tumour ne-
crosis is a histological prognostic factor albeit of a small
effect on its own [16]. The risk of incomplete excision and
the size of the tumour in relation to the breast is an onco-
plastic reason why mastectomy should be performed for
large tumours. A clear surgical margin is the only proven
protective factor [1,2].
There is no contraindication to immediate reconstruc-
tion after mastectomy in cases of giant phyllodes tumours
[17]. Malignant phyllodes tumours are best managed with
wide excision of normal breast tissue around the tumour
to obtain a 1 cm margin of normal- appearing breast tis-
sue, but very large malignant phyllodes tumours require
mastectomy [6]. With malignant tumours, 22% may give
rise to haematogenous metastasis most frequently to
the lungs. The role of adjuvant therapies (radiotherapy
and chemotherapy) is presently undefined and should be
tested in multicentre, prospective, randomized trials [18].
Conclusions
This case highlights the arguments for and against the
treatment of phyllodes tumour of the breast by breast-
conserving surgery. Breast-conserving surgery (wide tu-
mourectomy) may suffice for phyllodes tumour as it
has the advantage of cosmesis in a relatively benign
disease. It is not ideal for giant, multifocal phyllodes
and phyllodes of borderline or malignant pathology.
Close follow-up is required for detecting and treating
local recurrence following breast- conserving surgery.
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